Literature DB >> 1835137

Technetium 99m sestamibi in the assessment of chronic coronary artery disease.

D S Berman1, H Kiat, K Van Train, E Garcia, J Friedman, J Maddahi.   

Abstract

Extensive work has already been performed with regard to both planar and single photon emission computed (SPECT) technetium 99m sestamibi studies. Before widespread application of optimized acquisition and processing methods, clinical results between 99mTc sestamibi and thallium 201 were remarkably similar. It is anticipated that as techniques for 99mTc sestamibi planar and SPECT imaging become optimized, improvements in sensitivity and specificity for detection of coronary artery disease, over those observed with 201TI, might be forthcoming. This expectation is based on the improved image quality inherent in the use of the 99mTc agent with its higher count rate and higher energy. This improvement in image quality may be a principal reason for laboratories to switch from 201TI to 99mTc sestamibi imaging. It is anticipated that, with improved imaging characteristics, it will be easier for the average community hospital to obtain higher quality planar or SPECT imaging using 99mTc sestamibi rather than 201TI. In addition to improved image quality, the characteristics of 99mTc sestamibi allow gated planar or SPECT perfusion images to be obtained. It has been suggested that stress-gated SPECT sestamibi studies may provide all the information contained in a stress-rest nongated 99mTc sestamibi study, thereby potentially increasing patient throughput, a major concern with SPECT. Throughput can also be increased by using dual-isotope approaches with rest 201TI and stress technetium sestamibi acquisitions, employing either separate or simultaneous imaging with which the entire study can be accomplished in less than 2 hours. With simultaneous dual-isotope acquisition, camera time can be reduced by 50%. Finally, 99mTc sestamibi offers the advantage of the ability to perform first-pass exercise ventricular function and SPECT myocardial perfusion studies with a single injection of tracer. Regarding the assessment of myocardial viability, results to date suggest a very high degree of concordance between 201TI and 99mTc sestamibi studies using either planar or SPECT acquisition techniques. Correlative rest studies with both tracers will be of particular interest, as will preoperative and postoperative and position emission tomography correlation studies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835137     DOI: 10.1016/s0001-2998(05)80040-6

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  31 in total

1.  Comparison between segmental wall motion and wall thickening in patients with coronary artery disease using quantitative gated SPECT software.

Authors:  S L Rahman; S R Underwood
Journal:  Int J Card Imaging       Date:  2000-12

2.  Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease.

Authors:  A Elhendy; R T van Domburg; F B Sozzi; D Poldermans; J J Bax; J R Roelandt
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

3.  The accuracy of 1-day dual-isotope myocardial SPECT in a population with high prevalence of coronary artery disease.

Authors:  Reginald G E J Groutars; J Fred Verzijlbergen; Monique M C Tiel-van Buul; Aeilco H Zwinderman; Carl A P L Ascoop; Norbert M van Hemel; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2003-06       Impact factor: 2.357

4.  Myocardial perfusion and function single photon emission computed tomography.

Authors:  Christopher L Hansen; Richard A Goldstein; Daniel S Berman; Keith B Churchwell; C David Cooke; James R Corbett; S James Cullom; Seth T Dahlberg; James R Galt; Ravi K Garg; Gary V Heller; Mark C Hyun; Lynne L Johnson; April Mann; Benjamin D McCallister; Raymond Taillefer; R Parker Ward; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

5.  Phantom evaluation of simultaneous thallium-201/technetium-99m aquisition in single-photon emission tomography.

Authors:  Z Cao; C C Chen; C Maunoury; L E Holder; T C Abraham; A Tehan
Journal:  Eur J Nucl Med       Date:  1996-11

Review 6.  Nuclear medicine at the crossroads.

Authors:  H W Strauss
Journal:  Eur J Nucl Med       Date:  1996-06

7.  Tomographic and planar quantitation of perfusion defects on technetium 99m-labeled sestamibi scans: evaluation in patients treated with thrombolytic therapy for acute myocardial infarction.

Authors:  L A Mortelmans; F J Wackers; J L Nuyts; I A Scheys; T Brzostek; C W Schiepers; E E Lesaffre; P L Suetens; A M Verbruggen; F J Van de Werf
Journal:  J Nucl Cardiol       Date:  1995 Mar-Apr       Impact factor: 5.952

8.  Repeatability of treadmill exercise ejection fraction and wall motion using technetium 99m-labeled sestamibi first-pass radionuclide ventriculography.

Authors:  B Benari; H Kiat; J Erel; M Hyun; F P Wang; C Williams; J D Friedman; G Germano; K F Van Train; D Berman
Journal:  J Nucl Cardiol       Date:  1995 Nov-Dec       Impact factor: 5.952

9.  Correlation between ST elevation and Q waves on the predischarge electrocardiogram and the extent and location of MIBI perfusion defects in anterior myocardial infarction.

Authors:  Barak Zafrir; Nili Zafrir; Tuvia Ben Gal; Yehuda Adler; Zaza Iakobishvili; M Atiar Rahman; Yochai Birnbaum
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

10.  Prevalence, location, and extent of significant coronary artery disease in patients with normal myocardial perfusion imaging.

Authors:  Shu Yokota; Jan Paul Ottervanger; Mohamed Mouden; Jorik R Timmer; Siert Knollema; Pieter L Jager
Journal:  J Nucl Cardiol       Date:  2014-01-28       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.